Dexcom

Founded in 1999, Dexcom has been at the forefront of developing continuous glucose monitoring (CGM) systems that empower individuals to take control of their health. The company's flagship product, the Dexcom G7 CGM System, provides real-time glucose readings, enabling users to make informed decisions about their diabetes management. Designed for adults and children aged 2 and above who are on insulin or at risk for hypoglycemia, the Dexcom G7 offers unparalleled accuracy and seamless integration with various smart devices.

In addition to serving the diabetes community, Dexcom has expanded its offerings with the introduction of the Stelo Glucose Biosensor. This over-the-counter device is tailored for individuals aged 18 and older who are not on insulin but wish to monitor their glucose levels to inform their diet and exercise choices. Stelo delivers personal glucose insights directly to the user's smartphone, promoting healthier habits without the need for fingersticks or prescriptions.

By continually innovating and listening to the needs of users, caregivers, and healthcare providers, Dexcom simplifies and enhances glucose management, making it an integral part of daily life for many. Their commitment to excellence has solidified their position as a leader in diabetes care technology.